Allink Biotherapeutics
- Biotech or pharma, therapeutic R&D
Allink Biotherapeutics is a clinical-stage biotech founded in Sep 2023 . We have proprietary BsAb platform to develop bispecific antibodies with proprietary ADC conjugation technology. Our mission is to leverage our proprietary bispecific antibody and ADC platforms, along with efficient execution and business collaboration, to swiftly advance a diverse FIC and BIC therapeutical candidates with the highest potential.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}